TOCILIZUMAB AS MONOCLONAL ANTIBODY THERAPY IN OVERCOMING ACUTE RESPIRATORY DISTRESS SYNDROME IN COVID-19 PATIENTS. (2022). JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, 9(3), 92-101. https://doi.org/10.53366/jimki.v9i3.488